Sustained pharmacological activities in rats following single and repeated administration of once-a-month injectable microspheres of leuprolide acetate
- PMID: 1907735
- DOI: 10.1023/a:1015844421319
Sustained pharmacological activities in rats following single and repeated administration of once-a-month injectable microspheres of leuprolide acetate
Abstract
Once-a-month injectable microspheres of leuprolide acetate prepared with copoly(DL-lactic/glycolic acid) using an in-water drying method were assessed for duration of the analogue release and pharmacological effects in rats after a single or repeated injection. The periodic challenge test revealed that a single injection of the microspheres caused a dramatic and persistent suppression of the ability of the pituitary-gonadal system to secrete gonadotropin and testosterone for over 5 weeks. The complete recovery of these functions was observed 10 weeks after the injection. The repeated injection of the microspheres at intervals of 2 or 4 weeks achieved persistent suppression of steroidogenesis after an initial transient flare-up and beneficially avoided the "acute-on-chronic response." This depot formulation is expected to assure patient compliance and produce stronger therapeutic effects than the daily solution.
Similar articles
-
Pharmacokinetics of once-a-month injectable microspheres of leuprolide acetate.Pharm Res. 1991 Jun;8(6):787-91. doi: 10.1023/a:1015818504906. Pharm Res. 1991. PMID: 1905810
-
Sustained suppression of the pituitary-gonadal axis by leuprorelin three-month depot microspheres in rats and dogs.Pharm Res. 1994 Aug;11(8):1199-203. doi: 10.1023/a:1018905403359. Pharm Res. 1994. PMID: 7971724
-
Persistent suppression of the pituitary-gonadal system in female rats by three-month depot injectable microspheres of leuprorelin acetate.J Pharm Sci. 1996 Oct;85(10):1044-8. doi: 10.1021/js960123a. J Pharm Sci. 1996. PMID: 8897268
-
Clinical pharmacokinetics of depot leuprorelin.Clin Pharmacokinet. 2002;41(7):485-504. doi: 10.2165/00003088-200241070-00003. Clin Pharmacokinet. 2002. PMID: 12083977 Review.
-
[Once-a-month injectable microcapsules of leuprorelin acetate].Yakugaku Zasshi. 1991 Aug;111(8):397-409. doi: 10.1248/yakushi1947.111.8_397. Yakugaku Zasshi. 1991. PMID: 1795229 Review. Japanese.
Cited by
-
Leuprorelin. A review of its pharmacology and therapeutic use in prostatic cancer, endometriosis and other sex hormone-related disorders.Drugs. 1994 Dec;48(6):930-67. doi: 10.2165/00003495-199448060-00008. Drugs. 1994. PMID: 7533699 Review.
-
In vitro characterization and in vivo testosterone suppression of 6-month release poly(D,L-lactide) leuprolide microspheres.Pharm Res. 2002 Apr;19(4):546-50. doi: 10.1023/a:1015168301339. Pharm Res. 2002. PMID: 12033393 No abstract available.
-
Pharmacokinetics of once-a-month injectable microspheres of leuprolide acetate.Pharm Res. 1991 Jun;8(6):787-91. doi: 10.1023/a:1015818504906. Pharm Res. 1991. PMID: 1905810
-
Sustained suppression of the pituitary-gonadal axis by leuprorelin three-month depot microspheres in rats and dogs.Pharm Res. 1994 Aug;11(8):1199-203. doi: 10.1023/a:1018905403359. Pharm Res. 1994. PMID: 7971724
-
Dose and load studies for subcutaneous and oral delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin.Pharm Res. 1994 Jul;11(7):1009-15. doi: 10.1023/a:1018987404751. Pharm Res. 1994. PMID: 7937541
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources